In Brief: Dermaline Skin-Bleaching Cream
This article was originally published in The Rose Sheet
Executive Summary
Dermaline Skin-Bleaching Cream: Recalled by Little Ferry, N.J.-based Castillo Distributor, FDA says in its Nov. 27 Enforcement Report. The Class III (no adverse health effects likely) recall was initiated because "FDA analysis found" that the cream did not contain hydroquinone, which is listed as the active ingredient on product labeling. The recall extends to 1,152 8 oz. jars, 1,008 2 oz. jars and 34,512 4 oz. jars distributed in New York and New Jersey. According to Castillo, "little or no product remained on market at time of recall initiation," the Enforcement Report states. Santo Domingo, Dominican Republic-based Leivon Cosmetics manufactures the Dermaline cream...